Apgar score less than 7 at 5 minutes · women with severe intrapartum fetal bradycardia
1 finding from 1 review
Umbilical artery pH · women with severe intrapartum fetal bradycardia
1 finding from 1 review
Abnormal FHR tracing · women with severe intrapartum fetal bradycardia
It is very uncertain whether summary of findings for IV atosiban changes abnormal FHR tracing compared with IV hexoprenaline (very low certainty).
1 finding from 1 review
Perinatal death or severe morbidity · women with severe intrapartum fetal bradycardia
Summary of findings for IV atosiban showed no clear difference in perinatal death or severe morbidity compared with IV hexoprenaline (low certainty).
1 finding from 1 review
Fetal or neonatal mortality · women with severe intrapartum fetal bradycardia
1 finding from 1 review
Caesarean section · women with severe intrapartum fetal bradycardia
Summary of findings for IV atosiban showed no clear difference in caesarean delivery compared with IV hexoprenaline (low certainty).
1 finding from 1 review
Perinatal death or severe morbidity · women with non‐reassuring FHR tracing during labour or induction of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women with non‐reassuring FHR tracing during labour or induction of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · women with non‐reassuring FHR tracing during labour or induction of labour
Summary of findings for IV terbutaline showed no clear difference in caesarean delivery compared with IV nitroglycerin (low certainty).
1 finding from 1 review
Apgar score less than 7 at 5 minutes · women with non‐reassuring FHR tracing during labour or induction of labour
1 finding from 1 review
Umbilical artery pH < 7.0 · women with non‐reassuring FHR tracing during labour or induction of labour
It is very uncertain whether summary of findings for IV terbutaline changes umbilical artery pH < 7.0 compared with IV nitroglycerin (very low certainty).
1 finding from 1 review
Successful intrauterine fetal resuscitation · women with non‐reassuring FHR tracing during labour or induction of labour
Summary of findings for IV terbutaline showed no clear difference in successful intrauterine fetal resuscitation compared with IV nitroglycerin (low certainty).
1 finding from 1 review
Stopping breastfeeding (any) at 6 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus probably leads to lower stopping breastfeeding (any) at 6 months compared with usual care (moderate certainty).
1 finding from 1 review
Stopping exclusive breastfeeding at 6 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus may leads to lower stopping exclusive breastfeeding at 6 months compared with usual care (low certainty).
1 finding from 1 review
Stopping breastfeeding (any) at 4‐6 weeks · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 4‐6 weeks compared with usual care (moderate certainty).
1 finding from 1 review
Stopping exclusive breastfeeding at 4‐6 weeks · healthy breastfeeding women with healthy term babies
It is very uncertain whether summary of findings table ‐ Support plus changes stopping exclusive breastfeeding at 4‐6 weeks compared with usual care (very low certainty).
1 finding from 1 review
Stopping breastfeeding (any) at 2 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 2 months compared with usual care (moderate certainty).
1 finding from 1 review
Stopping exclusive breastfeeding at 2 months · healthy breastfeeding women with healthy term babies
It is very uncertain whether summary of findings table ‐ Support plus changes stopping exclusive breastfeeding at 2 months compared with usual care (very low certainty).
2 findings from 1 review
Stopping breastfeeding (any) at 3‐4 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 3‐4 months compared with usual care (low certainty).
1 finding from 1 review
Stopping breastfeeding (any) at 12 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 12 months compared with usual care (moderate certainty).
1 finding from 1 review